Immunologic approaches to the management of ovarian carcinoma
- PMID: 6207593
Immunologic approaches to the management of ovarian carcinoma
Similar articles
-
Immunotherapy for gynecologic malignancies.Prog Clin Biol Res. 1981;70:371-4. Prog Clin Biol Res. 1981. PMID: 7031696 Review. No abstract available.
-
Immune modulating therapy in gastrointestinal cancer.Am J Gastroenterol. 1986 Aug;81(8):623-8. Am J Gastroenterol. 1986. PMID: 2426941 Review. No abstract available.
-
Immunotherapy of human cancer.Adv Intern Med. 1977;22:145-85. Adv Intern Med. 1977. PMID: 65906 Review. No abstract available.
-
Immunologic therapies of kidney carcinoma.Semin Oncol. 1983 Dec;10(4):431-6. Semin Oncol. 1983. PMID: 6198729 Review. No abstract available.
-
Recent developments in immunomodulatory therapy.J Allergy Clin Immunol. 1985 Apr;75(4):423-40. doi: 10.1016/s0091-6749(85)80011-7. J Allergy Clin Immunol. 1985. PMID: 2579994 Review. No abstract available.
Cited by
-
Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients.Br J Cancer. 2001 Jun 15;84(12):1624-9. doi: 10.1054/bjoc.2001.1847. Br J Cancer. 2001. PMID: 11401315 Free PMC article.
-
Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.Cancer Immunol Immunother. 1988;27(3):246-54. doi: 10.1007/BF00205447. Cancer Immunol Immunother. 1988. PMID: 3180149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical